Sign in

CIK 0001600620

  • Large accelerated filer

Aurinia Pharmaceuticals Inc.

Sign in to watch
Ticker
AUPH
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
Operating
EIN
981231763
Phone
+1 250-744-2487
Business address
#140, 14315 - 118 AVENUE, EDMONTON, Alberta, Canada, T5L 4S6
  1. 4 Open-market sale EVP of Research sold 5,000 shares at $18.30 ($91,500)
  2. 4 Open-market sale Chief Business Officer sold 22,500 shares at $17.81 ($400,725)
  3. 4 Open-market sale Chief Medical Officer sold 5,000 shares at $15.85 ($79,250)
  4. 4 Open-market sale Chief Medical Officer sold 45,000 shares at $16.03 ($721,350)
  5. 4 Open-market sale Chief Business Officer sold 5,000 shares at $16.01 ($80,050)
  6. 4 Open-market sale Chief Business Officer sold 5,000 shares at $13.86 ($69,300)
  7. 4 Open-market sale Chief Business Officer sold 5,000 shares at $13.76 ($68,800)
  8. 4 Derivatives Options or other derivatives
  9. 3 Insider Initial Statement of Ownership
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 4 Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4 Open-market buy Director bought 4,500 shares at an average $11.23 ($50,529)
  18. 4 Open-market buy Ex VP, Intern'l Operations bought 9,900 shares at $10.07 ($99,739)
  19. 4 Open-market buy Chief Executive Officer bought 5,125 shares at an average $10.71 ($54,891)
  20. 4 Exercise or conversion Chief Business Officer acquired 20,000 shares (option exercise)

Page 8 of 10 · 184 filings